Pyxis Oncology, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-15.6M | $8.1M |
| FY2021 | — | $261.3M | $274.7M |
| FY2022 | — | $160.8M | $179.3M |
| FY2023 | — | $125.7M | $9.7M |
| FY2024 | — | $120.8M | $19.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-15.6M | $8.1M |
| FY2021 | — | $261.3M | $274.7M |
| FY2022 | — | $160.8M | $179.3M |
| FY2023 | — | $125.7M | $9.7M |
| FY2024 | — | $120.8M | $19.5M |